CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

BRAF V600E (thyroid cancer)

Gene: BRAF · Type: mutation

Indications: Anaplastic thyroid cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
DabrafenibAnaplastic thyroid cancerINDICATED
FDA Label
Label
TrametinibAnaplastic thyroid cancerINDICATED
FDA Label
Label